ICICI Prudential Life: ICICI Sec sets ₹705 target (2026)

What changed in the latest broker note

ICICI Securities reiterated a BUY call on ICICI Prudential Life Insurance Company (IPRU) with a target price of ₹705 in a report dated April 20, 2026. The brokerage note points to a recovery in retail APE in H2FY26, alongside a VNB margin that held up through FY26. The view also leans on the insurer’s sustained ability to deliver about 13% ROEV, which ICICI Securities describes as supportive for valuations. At the same time, the brokerage flags that its multiple has been cut to reflect lower volume growth, even while keeping the rating positive. The overall stance is framed around balancing volume growth and margin outcomes into FY28. The note also highlights that IPRU is relatively better placed on risks of channel disruption from adverse regulation due to a diversified channel mix.

Retail APE recovery in H2FY26

The key near-term operational datapoint cited is the pick-up in retail APE in the second half of FY26. ICICI Securities notes that retail APE recovered in H2FY26, with October to February growth of 8.8%. This suggests momentum improved after a softer start, helping the broker build confidence around trajectory into the next few quarters. The recovery in retail APE matters because it is one of the most tracked indicators of new business traction for life insurers. It also ties directly into the pace of Embedded Value (EV) growth when combined with profitability. In the broker’s framing, the emphasis remains on scaling APE on an absolute basis rather than relying only on margin expansion.

VNB margin stays resilient despite FY26 hurdles

ICICI Securities reported that the VNB margin stood at 24.7% in FY26 despite multiple headwinds. The brokerage explicitly lists non-availability of input tax credits after the removal of GST and a drop in persistency as hurdles during the year. Even with these pressures, the margin outcome keeps the base around the ~25% level, which the report treats as the new reference range. This is important because VNB margin is central to how investors judge the quality of growth in new business. The note also suggests there is scope for IPRU to optimise margins through product mix fluctuations, implying management can influence profitability by shifting sales composition. Still, the report does not claim this improvement is assured, and keeps the focus on balancing volume and margin.

Why the brokerage thinks valuations are still attractive

The brokerage view is that valuations remain attractive, supported by IPRU’s ability to register around 13% ROEV. ICICI Securities also points to potential improvements ahead, although it does not quantify those improvements in the provided text. A key part of the outlook is EV growth till FY28, with the rating intended to capture that potential. However, the note adds that the multiple has been cut due to lower volume growth, signalling that the positive view is not based on an aggressive growth assumption. In practical terms, the call rests on sustaining returns and holding margins near current levels while continuing to expand the new business base. The report also underlines that the company’s diversified mix reduces the risk of channel disruption if regulations turn adverse.

Targets and recent market context from published data

Published market data shows IPRU has seen varied price points and targets across sources. ETPrime data cited in the text shows the share price moved down 1.89% from a previous close of ₹540.60 to ₹530.40. Separately, exchange-style data points in the text show ICICIPRULI at 651.35 (close 651.30) as on 20-Feb-2026, with a 52-week high of 706.80 (13-Jan-2026) and 52-week low of 525.80 (07-Apr-2025). The ETPrime snapshot also references “Mean Recos by 34 Analysts” and lists examples of targets such as ₹650 (JM Financial) and ₹780 (Motilal Oswal Financial Services). These numbers provide context on how the stock has traded and how targets differ across brokerages.

ICICI Bank’s plan to buy up to 2% more stake

Another relevant corporate development in the provided text is ICICI Bank’s board approval to purchase up to 2.0% additional shareholding in ICICI Prudential Life. The board meeting concluded on February 28, 2026, and the stated objective was to maintain the bank’s majority shareholding, particularly if employee stock-based compensation exercises dilute the ownership percentage. The transaction is subject to regulatory approvals, which is standard for such moves in financial services. This update does not directly change the insurer’s operating metrics, but it signals the parent’s intent to preserve control. Around this event, the text also cites a trading snapshot where ICICI Prudential Life last traded at ₹654.45 versus a previous close of ₹674.00, with an intraday high of ₹683.00 and low of 649.05.

Key numbers at a glance

Market impact: what investors are likely to track

For investors, the most immediate takeaways are the APE recovery signal and the resilience of VNB margin at 24.7% in FY26 despite the hurdles mentioned. If the margin base is indeed now around ~25%, then incremental changes in product mix and persistency trends can meaningfully influence profitability optics. The BUY call with a ₹705 target makes the brokerage’s stance clear, but the note also flags lower volume growth through a cut in multiple, which is an explicit caution on growth expectations. The separate disclosure about ICICI Bank’s intent to buy up to 2% more stake is structurally important because it addresses potential dilution from stock-based compensation and the parent’s desire to maintain majority ownership. In day-to-day trading context, the text highlights both a decline to ₹530.40 in one snapshot and a separate price reference of 651.35 (20-Feb-2026), underlining that readers should anchor interpretation to the specific date and data source cited.

Analysis: why this setup matters into FY28

The brokerage’s framing focuses on EV growth till FY28 while balancing volume and margin, which is a common lens for valuing life insurers. With VNB margin at 24.7% for FY26 and an outlook base of ~25%, the debate shifts to whether growth can accelerate without giving up profitability. The cited hurdles, such as non-availability of input tax credits post removal of GST and a drop in persistency, show that maintaining margin was not frictionless in FY26. The comment that IPRU could optimise margins through product mix fluctuations indicates that execution and sales mix will remain central to results interpretation. The reference to diversified channels reducing adverse regulation risk also matters because distribution rules can affect how insurers write business and at what cost. Investors will likely compare IPRU’s APE traction and margin stability against peer outcomes as the next disclosures emerge.

Conclusion

ICICI Securities’ April 20, 2026 note keeps a BUY rating on ICICI Prudential Life with a ₹705 target, pointing to an H2FY26 retail APE recovery and FY26 VNB margin of 24.7%. The stated focus remains on growing APE and VNB in absolute terms, with the VNB margin base set around ~25%. Separately, ICICI Bank’s board has approved buying up to 2% additional stake in IPRU, subject to regulatory approvals, to maintain majority ownership. The next set of updates investors will watch are future disclosures that confirm whether APE momentum continues and whether margins hold near the ~25% range.